Harrow (HROW) EBIT Margin Growth (3y) (2016 - 2026)
Harrow (HROW) EBIT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn | -2,260.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,260.00 |
| Mar 31, 2026 | -5,459.00 |
| Dec 31, 2025 | 2,625.00 |
| Sep 30, 2025 | 2,100.00 |
| Jun 30, 2025 | 1,065.00 |
| Mar 31, 2025 | -3,298.00 |
| Dec 31, 2024 | 2,799.00 |
| Sep 30, 2024 | 2,255.00 |
| Jun 30, 2024 | -1,986.00 |
| Mar 31, 2024 | -3,892.00 |
| Dec 31, 2023 | -3,140.00 |
| Sep 30, 2023 | -600.00 |
| Jun 30, 2023 | 4,685.00 |
| Mar 31, 2023 | 995.00 |
| Dec 31, 2022 | -1,609.00 |
| Sep 30, 2022 | 3,407.00 |
| Jun 30, 2022 | 1,292.00 |
| Mar 31, 2022 | 1,402.00 |
| Dec 31, 2021 | 1,031.00 |
| Sep 30, 2021 | -1,382.00 |